These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16756588)

  • 1. Quetiapine-induced acute dystonia and akathisia.
    Desarkar P; Sinha VK
    Aust N Z J Psychiatry; 2006; 40(6-7):607-8. PubMed ID: 16756588
    [No Abstract]   [Full Text] [Related]  

  • 2. Parkinsonism and akathisia with quetiapine: three case reports.
    Bharadwaj R; Grover S
    J Clin Psychiatry; 2008 Jul; 69(7):1189-91. PubMed ID: 18687022
    [No Abstract]   [Full Text] [Related]  

  • 3. Paradoxical severe agitation induced by add-on high-doses quetiapine in schizo-affective disorder.
    Fond G; MacGregor A; Ducasse D; Brittner M
    Psychiatry Res; 2014 May; 216(2):286-7. PubMed ID: 24582773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quetiapine-induced dystonia and agitation in Parkinson's disease with dementia: a case report.
    Leey J; Setters B; Murphy P; Antimisiaris D; Miles T
    J Am Geriatr Soc; 2009 May; 57(5):918-9. PubMed ID: 19470011
    [No Abstract]   [Full Text] [Related]  

  • 5. Tardive dyskinesia with quetiapine.
    Ghelber D; Belmaker RH
    Am J Psychiatry; 1999 May; 156(5):796-7. PubMed ID: 10327920
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety of quetiapine during pregnancy.
    Taylor TM; O'Toole MS; Ohlsen RI; Walters J; Pilowsky LS
    Am J Psychiatry; 2003 Mar; 160(3):588-9. PubMed ID: 12611848
    [No Abstract]   [Full Text] [Related]  

  • 7. Tolerability of extended-release quetiapine fumarate compared with immediate-release quetiapine fumarate in older patients with Alzheimer's disease with symptoms of psychosis and/or agitation: a randomised, double-blind, parallel-group study.
    De Deyn PP; Eriksson H; Svensson H;
    Int J Geriatr Psychiatry; 2012 Mar; 27(3):296-304. PubMed ID: 21538537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute dystonia with quetiapine.
    Jonnalagada JR; Norton JW
    Clin Neuropharmacol; 2000; 23(4):229-30. PubMed ID: 11020131
    [No Abstract]   [Full Text] [Related]  

  • 9. Quetiapine for agitation or psychosis in patients with dementia and parkinsonism.
    Kurlan R; Cummings J; Raman R; Thal L;
    Neurology; 2007 Apr; 68(17):1356-63. PubMed ID: 17452579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quetiapine-Induced extrapyramidal side effects in patients with Parkinson's disease: case report.
    Sommer BR
    J Geriatr Psychiatry Neurol; 2001; 14(2):99-100. PubMed ID: 11419575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pilot, open-label safety study of quetiapine for treatment of moderate psychotic agitation in the emergency setting.
    Currier GW; Trenton AJ; Walsh PG; van Wijngaarden E
    J Psychiatr Pract; 2006 Jul; 12(4):223-8. PubMed ID: 16883147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of tardive dystonia successfully managed with quetiapine.
    Sasaki Y; Kusumi I; Koyama T
    J Clin Psychiatry; 2004 Apr; 65(4):583-4. PubMed ID: 15119928
    [No Abstract]   [Full Text] [Related]  

  • 13. A study of quetiapine: efficacy and tolerability in psychotic adolescents.
    Shaw JA; Lewis JE; Pascal S; Sharma RK; Rodriguez RA; Guillen R; Pupo-Guillen M
    J Child Adolesc Psychopharmacol; 2001; 11(4):415-24. PubMed ID: 11838824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral risperidone, olanzapine and quetiapine versus haloperidol in psychotic agitation.
    Villari V; Rocca P; Fonzo V; Montemagni C; Pandullo P; Bogetto F
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):405-13. PubMed ID: 17900775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quetiapine in the treatment of behavioral disturbances in patients with Huntington's disease.
    Alpay M; Koroshetz WJ
    Psychosomatics; 2006; 47(1):70-2. PubMed ID: 16384811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quetiapine treatment in early psychosis: no evidence of cataracts.
    Whitehorn D; Gallant J; Woodley H; Rui Q; Milliken H; Kopala L
    Schizophr Res; 2004 Dec; 71(2-3):511-2. PubMed ID: 15474924
    [No Abstract]   [Full Text] [Related]  

  • 17. Quetiapine and leukopenia.
    Clark N; Weissberg E; Noel J
    Am J Psychiatry; 2001 May; 158(5):817-8. PubMed ID: 11329413
    [No Abstract]   [Full Text] [Related]  

  • 18. Quetiapine-associated hypomania in a woman with schizoaffective disorder.
    Benazzi F
    Can J Psychiatry; 2001 Mar; 46(2):182-3. PubMed ID: 11280090
    [No Abstract]   [Full Text] [Related]  

  • 19. Assessment of EPS and tardive dyskinesia in clinical trials. Collaborative Working Group on Clinical Trial Evaluations.
    J Clin Psychiatry; 1998; 59 Suppl 12():23-7. PubMed ID: 9766616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quetiapine and falsely elevated nortriptyline level.
    Schussler JM; Juenke JM; Schussler I
    Am J Psychiatry; 2003 Mar; 160(3):589. PubMed ID: 12611850
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.